Related references
Note: Only part of the references are listed.2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Management of cutaneous manifestations of lupus erythematosus: A systematic review
J. L. Fairley et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
Michelle Petri et al.
ARTHRITIS & RHEUMATOLOGY (2020)
EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies
Manuel Ramos-Casals et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus
Leonid D. Zamora et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission
Margherita Zen et al.
RHEUMATOLOGY (2020)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study
Evrydiki Kravvariti et al.
AUTOIMMUNITY REVIEWS (2020)
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort
Matteo Piga et al.
RHEUMATOLOGY (2020)
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Use of antimalarial drugs is associated with a lower risk of preeclampsia in lupus pregnancy: A prospective cohort study
Miguel Angel Saavedra et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)
Hydroxychloroquine and COVID-19
Neeraj Sinha et al.
POSTGRADUATE MEDICAL JOURNAL (2020)
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
Katelyn A. Pastick et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
Robert B. M. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
Eliise Laura Nirk et al.
EMBO MOLECULAR MEDICINE (2020)
Q Fever (Coxiella Burnetii)
Pedro Pablo Espana et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed A. C. Siemieniuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial
Shaoying Yang et al.
TRIALS (2020)
Trend of Survival of a Cohort of Chinese Patients With Systemic Lupus Erythematosus Over 25 Years
Chi Chiu Mok et al.
FRONTIERS IN MEDICINE (2020)
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
Ruth Fernandez-Ruiz et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Psoriatic Arthritis Treatment Patterns and Costs Among Pharmacologic Treatment-Naive Patients
Ervant J. Maksabedian Hernandez et al.
AMERICAN JOURNAL OF MANAGED CARE (2020)
Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus
Ileana Vazquez-Otero et al.
LUPUS SCIENCE & MEDICINE (2020)
Leflunomide-hydroxychloroquine combination therapy in patients with primary Sjogren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial
Eefje Hanna Martine van der Heijden et al.
LANCET RHEUMATOLOGY (2020)
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia
M. R. Seo et al.
LUPUS (2019)
Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients A systematic review and meta-analysis
Chen-Yang Tao et al.
MEDICINE (2019)
Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjogren's syndrome
Eefje H. M. van der Heijden et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort
V. R. Pimentel-Quiroz et al.
LUPUS (2019)
Causes and factors related to hospitalizations in patients with systemic lupus erythematosus: analysis of a 20-year period (1995-2015) from a single referral centre in Catalonia
G. Pires da Rosa et al.
LUPUS (2019)
Causes and Factors Associated with Frequent Hospitalization in Chinese Patients with Systemic Lupus Erythematosus: An Ambispective Cohort Study
Han Liang et al.
MEDICAL SCIENCE MONITOR (2019)
Changing paradigms in the treatment of systemic lupus erythematosus
Antonis Fanouriakis et al.
LUPUS SCIENCE & MEDICINE (2019)
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
Aurelie Najm et al.
RMD OPEN (2019)
Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis
Hamayon Babary et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis
R. Pakchotanon et al.
LUPUS (2018)
Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort
C. C. Mok et al.
LUPUS (2018)
Arthritis in sarcoidosis: A multicentric study from India
Vikas Agarwal et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis
Paige W. Wolstencroft et al.
JAMA DERMATOLOGY (2018)
Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort
C. Gonzalez-Echavarri et al.
LUPUS (2018)
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
L. Andreoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Research progress of hydroxychloroquine and autophagy inhibitors on cancer
Ting-Ting Shi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Hydroxychloroquine in systemic lupus erythematosus (SLE)
C. Ponticelli et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano et al.
JOURNAL OF RHEUMATOLOGY (2017)
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Rohit Aggarwal et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis
F. Chasset et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies
S. Sciascia et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
M. Yates et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjogren's Syndrome: A Double-Blind Randomized Control Study
Chang Ho Yoon et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy
Laura Durcan et al.
JOURNAL OF RHEUMATOLOGY (2016)
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Michael F. Marmor et al.
OPHTHALMOLOGY (2016)
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies
Savino Sciascia et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study
Yi-Ming Chen et al.
RHEUMATOLOGY (2015)
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
M. Jallouli et al.
ARTHRITIS & RHEUMATOLOGY (2015)
The Clinical Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis Data From a French Nationwide Study of Fifty-Seven Patients
Marie Jachiet et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
K. D. Rainsford et al.
INFLAMMOPHARMACOLOGY (2015)
Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjogren Syndrome The JOQUER Randomized Clinical Trial
Jacques-Eric Gottenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
Nathalie Costedoat-Chalumeau et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review
Petar Lenert et al.
CLINICAL RHEUMATOLOGY (2013)
Antimicrobial therapies for Q fever
Gilbert J. Kersh
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Multifaceted effects of hydroxychloroquine in human disease
Nancy J. Olsen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
Ronald F. van Vollenhoven et al.
LANCET (2012)
Predictors of survival in Chinese patients with lupus nephritis
Z. H. Zheng et al.
LUPUS (2012)
Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody-Positive Patients
Michelle Petri
CURRENT RHEUMATOLOGY REPORTS (2011)
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
Peter M. Izmirly et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Protective Effect of Antimalarial Drugs on Thrombovascular Events in Systemic Lupus Erythematosus
Hyejung Jung et al.
ARTHRITIS AND RHEUMATISM (2010)
Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Sara Kaprove Penn et al.
JOURNAL OF RHEUMATOLOGY (2010)
Articular manifestations in primary Sjogren's syndrome: clinical significance and prognosis of 188 patients
Anne-Laure Fauchais et al.
RHEUMATOLOGY (2010)
Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease
Vicente Giner Galvan et al.
CLINICAL RHEUMATOLOGY (2007)
Medical progress - Whipple's disease
Florence Fenollar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Combination antimalarials in the treatment of cutaneous dermatomyositis - A retrospective study
GC Ang et al.
ARCHIVES OF DERMATOLOGY (2005)
Cutaneous hyperpigmentation during therapy with hydroxychloroquine
TP Millard et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2004)
Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications - Results of a two-year, randomized, double-blind, placebo-controlled trial
JR O'Dell et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
